A Community Collaboration Between IU Health and St. Vincent
Current Studies & Research
The interFACE Lab

The interFACE Lab The Interactive and Functional Assessment of Communication and Emotion (InterFACE) Center is a natural observation laboratory designed to research emotional and behavioral deficits in people with neurological,… Read More

TrackTBI

TrackTBI Investigator: Richard Rodgers, MD TRACK-TBI:  The multicenter Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study aims to improve success of clinical trial design through the collection and analysis of… Read More

Training to Reconnect with emotional awareness therapy

Training to Reconnect with emotional awareness therapy (TREAT) Investigators: Dawn Neumann, Flora Hammond The purpose of this study is to teach participants with traumatic brain injury to develop better emotional… Read More

Avanir Study

Avanir Study Sheryl Katta-Charles MD, Principal Investigator A Phase 2, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability or AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for… Read More

Monitoring Safety and Training in Patients with Spinal Cord Injuries

Long-Term, Prospective, Non-Interventional Study Monitoring Safety and Training in Patients with Spinal Cord Injuries and Their Trained Companions Recently Initiated with the ReWalk™ Personal Device. Flora Hammond, MD (PI), funded… Read More

SEE ALL RESEARCH
BACK
Post-TBI Irritability & Aggression: Building Evidence-Based Approaches to Management April 26th, 2013

       Flora Hammond, MD (PI), James Malec, PhD (Co-PI), Jacob Kean, PhD, Susan Perkins, PhD, Patrick Monahan, PhD, funded by National Institute on Disability and Rehabilitation Research (NIDRR).

 

  • Treatment and Placebo Arm: “Buspirone for the Treatment of Chronic Post-TBI Irritability and Aggression: A 91-Day Single- Site, Flexible-Dose, Parallel Group, Randomized, Placebo-Controlled Trial”
  • Measurement Arm: “Preliminary Development of the Aggression and Irritability Impact Measure”

 

PURPOSE OF PROJECT: To study the effect expressed by persons with TBI through assessment of buspirone effectiveness for post-traumatic irritability and aggression and development of an irritability/aggression impact measure.

 

SUMMARY OF PROJECT: It is anticipated that 74 subjects with 74 corresponding subject observers will be recruited for the treatment study. Subjects will be recruited from community and self-referrals.

 

Contact Person:  Becky Runkel, at becky.runkel@rhin.com , or at (317) 329-2217.